News Releases

April 2019

April 2, 2019 4/2/2019 Motegrity™ (prucalopride), the Only Serotonin-4 Receptor Agonist for Adults with Chronic Idiopathic Constipation (CIC), is Now Available in the United States

March 2019

March 18, 2019 3/18/2019 Takeda receives U.S. FDA Approval to Manufacture FLEXBUMIN

January 2019

January 11, 2019 1/11/2019 Takeda Announces Outcome of Uloric FDA Advisory Committee Meeting

October 2018

October 26, 2018 10/26/2018 New Study Used Personalized Goals to Assess Treatment Effectiveness for Patients with Major Depressive Disorder

October 22, 2018 10/22/2018 New Data Added to TRINTELLIX® (vortioxetine) Labeling

October 21, 2018 10/21/2018 Takeda Announces Additional Analyses of Results from Uloric® (febuxostat) Cardiovascular Outcomes Trial

October 8, 2018 10/8/2018 New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients

October 5, 2018 10/5/2018 Takeda Donates more than $130,000 to Local, Regional Charities at Annual Takeda Cares Day Event